Company / Return on Assets (ROA)
Sana Biotechnology, Inc. Return on Assets (ROA) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-53.2%
FY2024
5-year range
-53.2% / -31.5%
FY2020-FY2024
Trend
-6.2%
vs FY2023
Sector context
#181 of 213
Health Care
What the data says
Sana Biotechnology, Inc.'s return on assets (roa) of -53.2% is lower than 85% of companies in the Health Care sector (FY2024). Return on Assets (ROA) has declined for 3 consecutive years, from -31.5% in FY2021 to -53.2% in FY2024.
Based on SEC 10-K filings.
-53.2% in FY2024 with a 3-year CAGR of -21.7%.
Declined from -32.8% to -53.2% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -21.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 213This company -53.2% Sector average -24.1%
▼
-120.6% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s return on assets (roa) has declined for 3 consecutive years.
- In FY2024, return on assets (roa) decreased 6.2% year-over-year.
- Currently 29.1pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -53.2% | -6.2% |
| FY2023 | -50.1% | -53.0% |
| FY2022 | -32.8% | -3.9% |
| FY2021 | -31.5% | +19.3% |
| FY2020 | -39.1% | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026